Sarepta Therapeutics (SRPT) in focus as the biotech says the death of a patient who had received its gene therapy Elevidys ...

Jyong Biotech targets urinary disorders with a novel botanical pipeline, but clinical and liquidity risks temper near-term ...

See here for a 3-bucket portfolio offering 5-6% income, market-beating growth, and reduced volatility—ideal for retirees ...

Bloom Energy surged on AI hype and an Oracle deal, but valuation looks stretched and risks are rising ahead of earnings. Read ...

Lithium Argentina sees strong Q1 2025 margins, scalable growth to 200K+ tons with DLE tech, and untapped upside from ...

Discover why VeriSign (VRSN) earns a neutral hold rating. Explore strong profit margins, resumed dividends, and key risks ...

NerdWallet’s shift toward vertical integration is boosting profitability, with shares trading cheaply relative to growth. See ...

Dow faces significant headwinds, tariffs, and weak global demand. Is it a good time to buy the dip after the dividend cut and ...

Workday is a compelling Buy opportunity with strong margins, AI potential, and 20-30% upside despite growth concerns. Read ...

US President Donald Trump said July 8 that the administration would imminently impose a 50% tariff on copper product imports, ...

Alphabet is growing fast in core and cloud segments, though rising AI capex is pressuring free cash flow and returns. Learn ...

Ero Copper operates key Brazilian copper and gold assets, with new production ramping up and rising capital demands. See why ...